Navigation Links
Pharmaceutical and Medical Device Patent Portfolio Acquisition Opportunities from ICAP Patent Brokerage
Date:9/4/2013

NEW YORK, Sept. 4, 2013 /PRNewswire/ -- ICAP Patent Brokerage announces innovative pharmaceutical and medical device patent portfolios available for sale via private brokerage.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

"­­­­­­­­­­­­­­­­­­­­­­­­­­We are thrilled to offer such strong patent portfolios disclosing key advancements for the medical and pharmaceutical industry. The cutting-edge inventions developed in this space and now available for sale have endless possibilities – most importantly improved medical care and enhanced quality of life – when matched with the right buyer," says Dean Becker, CEO of ICAP Patent Brokerage.

Patent Portfolios for Sale
The assets available for sale disclose key innovations relevant to these exciting technology sectors, including:

  • Material for Orthopedic Applications
  • Enhanced Topical Analgesic Cream
  • and more!

Click here to see a complete catalog of the pharmaceutical and medical device patent portfolios available for sale.

To learn more about the assets available for sale:
Contact Paul Greco of ICAP Patent Brokerage at (212) 815-6692 or via email at Paul.Greco@us.icap.com.

Follow us on Twitter (@ICAP_Auction_IP) and join our LinkedIn group.

About ICAP Patent Brokerage

ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP

ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through its post trade risk mitigation and information services ICAP helps customers manage and mitigate risks in their portfolios. For more information, go to www.icap.com.


'/>"/>
SOURCE ICAP Patent Brokerage
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
2. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
3. Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
4. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
5. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
6. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
7. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
8. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
9. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
10. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
11. Pharmaceutical Industry Relies on Medical Science Liaisons to Generate Value across a Diverse Set of Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
(Date:4/27/2016)... 27, 2016 Tie-up with Government ... to save newborns   Fortis La ... newborns in collaboration with Breast Milk Foundation (BMF), a non-profit ... Human Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit centre ... for infants and should be available to babies deprived of ...
(Date:4/27/2016)... NEW YORK , April 27, 2016 /PRNewswire/ ... OASM ), a developer of a new ... today announced positive overall survival results for Paclical/Apealea ... total of 789 patients with epithelial ovarian cancer. ... treatment groups: Paclical/Apealea in combination with carboplatin versus ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... Saturday, April 30, marks World ... on public health. The World Veterinary Association (WVA) and the World Organization for ... continuing education with a One Health focus, which emphasizes how veterinarians pursue continuing ...
(Date:4/30/2016)... ... ... for all of us, but there are things we can do to improve the odds of ... more and more that there are simple, yet important steps that can be taken to maintain ... Kohli’s recommends for her patients include;, , exercise , ...
(Date:4/29/2016)... (PRWEB) , ... April 30, 2016 , ... Mercy College ... campus. The following programs will be expanding due to high demand: Master of ... The expansion will begin this summer. , School of Business Graduate Program ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Accreditation Council for Graduate Medical Education (ACGME) that it has received accreditation for ... first accreditation of three residency programs that Memorial is currently pursuing, including Pediatrics ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
Breaking Medicine News(10 mins):